Optical Coherence Tomography Market Worth $1.8 Billion by 2024: Grand View Research, Inc.

Improvement in the design of the devices along with utility of advanced software is expected to enhance the healthcare provider's ability to accurately diagnose and manage chronic conditions. For instance, Optovue launched AngioVue Retina in June 2016 , which is expected to provide ophthalmologist with a smooth integration of the optical coherence tomography angiography technology into the workflow.

Government support towards increased diagnostic rate is another vital impact rendering driver. For instance, the U.S. FDA have launched multiple programs to facilitate routine screening of geriatric patients, which forms a large portion of the target group. Availability of favorable reimbursement, is further expected to increase the diagnostic rate for conditions such as age-related macular degeneration, retinopathy, vitreomacular traction along with various other conditions.

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco . The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: